128 related articles for article (PubMed ID: 32668858)
21. [A Case of Locally Advanced and Metastatic Breast Cancer Treated with Preoperative Bevacizumab Combination Chemotherapy That Attained Local Control].
Watanabe N; Furukawa J; Minoji T; Tamai K; Kitahara T; Yamamura N; Okamura S; Fukuchi N; Ebisui C; Yokouchi H; Kinuta M
Gan To Kagaku Ryoho; 2018 Jul; 45(7):1097-1099. PubMed ID: 30042280
[TBL] [Abstract][Full Text] [Related]
22. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
[TBL] [Abstract][Full Text] [Related]
23. [Radiotherapy and Eribulin Mesylate for Mediastinal Node Metastasis from Breast Cancer-A Case Report].
Ishizuka M; Tsubota Y; Sueoka N; Chiba T; Miyata M; Yoshikawa K; Yamamoto D
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2177-2179. PubMed ID: 30692323
[TBL] [Abstract][Full Text] [Related]
24. [A Case of Metastatic Breast Cancer with BRCA1 Mutation after Breast Reconstruction and Pregnancy].
Suzuki T; Hashimoto N; Yokoyama K; Yoshida T; Yamauchi Y; Sawano T; Ohashi M; Kimura A; Kato M; Umehara Y; Murata A; Takahash K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1840-1842. PubMed ID: 35046348
[TBL] [Abstract][Full Text] [Related]
25. Olaparib Keeps Hereditary Breast Tumors in Check.
Cancer Discov; 2017 Aug; 7(8):OF10. PubMed ID: 28583909
[TBL] [Abstract][Full Text] [Related]
26. Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
Ledermann JA; Harter P; Gourley C; Friedlander M; Vergote I; Rustin G; Scott C; Meier W; Shapira-Frommer R; Safra T; Matei D; Fielding A; Spencer S; Rowe P; Lowe E; Hodgson D; Sovak MA; Matulonis U
Lancet Oncol; 2016 Nov; 17(11):1579-1589. PubMed ID: 27617661
[TBL] [Abstract][Full Text] [Related]
27. [Combination Therapy of Bevacizumab plus Paclitaxel Was Effective for a Metastatic Choroidal Tumor Secondary to Breast Cancer in a Patient with Ocular Symptoms].
Hattori M; Shirahane K; Sakai M; Sassa Y; Nishihara Y; Aibe H; Masuda M; Mori D
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1221-1224. PubMed ID: 32829359
[TBL] [Abstract][Full Text] [Related]
28. [Recurrence of skin and lymph nodes from asynchronous breast cancer successfully treated with paclitaxel and toremifene therapy--a case report].
Sakurai K; Enomoto K; Tani M; Kitajima A; Amano S; Shiono M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2222-4. PubMed ID: 19106577
[TBL] [Abstract][Full Text] [Related]
29. Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells.
Shimo T; Kurebayashi J; Kanomata N; Yamashita T; Kozuka Y; Moriya T; Sonoo H
Breast Cancer; 2014 Jan; 21(1):75-85. PubMed ID: 22454224
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy.
Sekine C; Nakano S; Mibu A; Otsuka M; Oinuma T; Takeyama H
Asian J Surg; 2020 Jan; 43(1):148-153. PubMed ID: 31153730
[TBL] [Abstract][Full Text] [Related]
31. PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms.
Matthews Hew T; Zuberi L
J Investig Med High Impact Case Rep; 2019; 7():2324709619864989. PubMed ID: 31375040
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer.
Secord AA; Barnett JC; Ledermann JA; Peterson BL; Myers ER; Havrilesky LJ
Int J Gynecol Cancer; 2013 Jun; 23(5):846-52. PubMed ID: 23666017
[TBL] [Abstract][Full Text] [Related]
33. [A Case of a Breast Cancer Patient with Cardiac Metastasis].
Konishi K; Araya J; Nagabuchi M; Sakamoto T; Murai D
Gan To Kagaku Ryoho; 2018 Dec; 45(12):1763-1765. PubMed ID: 30587737
[TBL] [Abstract][Full Text] [Related]
34. Olaparib tablets for the treatment of germ line BRCA-mutated metastatic breast cancer.
Le D; Gelmon KA
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):833-839. PubMed ID: 30118334
[TBL] [Abstract][Full Text] [Related]
35. [A Case of Male Recurrent Breast Cancer Successfully Treated with Bevacizumab plus Paclitaxel Therapy for Carcinomatous Pericarditis].
Nara M; Oshino T; Hagio K; Takazaki E; Yamashita H
Gan To Kagaku Ryoho; 2020 Jul; 47(7):1085-1087. PubMed ID: 32668857
[TBL] [Abstract][Full Text] [Related]
36. [A Case of Chemotherapy with Low-Dose Paclitaxel and Bevacizumab for Elderly Recurrent Breast Cancer Patient].
Munemoto M; Kano S; Ishikawa S; Makita N; Yagi Y; Oonishi I; Kayahara M
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2038-2040. PubMed ID: 33468793
[TBL] [Abstract][Full Text] [Related]
37. [A long-term survival case of local recurrence of breast cancer treated with combined modality therapy].
Katsuta E; Ohkubo T; Someno Y; Saguchi M; Aoyagi H; Takahata T; Hasegawa K; Hamada S; Kaneko J; Maejima S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2760-2. PubMed ID: 21224704
[TBL] [Abstract][Full Text] [Related]
38. [A case of recurrent breast cancer with carcinomatous pleurisy successfully treated with combined chemoendocrine-therapy of CTF (CPA, THP and 5-FU) and anastrozole following instillation therapy 12 years after radical mastectomy].
Mori K; Chiba N; Yamamoto Y; Yonekawa H
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2565-8. PubMed ID: 12506484
[TBL] [Abstract][Full Text] [Related]
39. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
40. Two cases with long-term disease-free survival after resection and radiotherapy for solitary brain metastasis from breast cancer with extensive nodal metastases.
Saisho S; Takashima S; Ohsumi S; Saeki H; Aogi K; Saeki T; Mandai K; Iwata S; Takeda T
Breast Cancer; 2005; 12(3):221-5. PubMed ID: 16110293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]